Humacyte, Inc. Class Action Lawsuit Alert: Johnson Fistel Announces Shareholders with Losses Should Contact the Law Firm for More Information
Portfolio Pulse from
A class action lawsuit has been filed against Humacyte, Inc. (NASDAQ: HUMA) by Johnson Fistel, LLP. The lawsuit aims to recover losses for investors who acquired Humacyte securities between May 10, 2024, and October 17, 2024. Investors have until January 17, 2025, to apply to be lead plaintiff.
December 19, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Humacyte, Inc. faces a class action lawsuit filed by Johnson Fistel, LLP, which could impact its stock price negatively in the short term. The lawsuit is on behalf of investors who acquired securities between May 10, 2024, and October 17, 2024.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential financial liabilities and reputational damage. The lawsuit is directly related to Humacyte's securities, making it highly relevant and important for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100